This research proposes a model-based dermatopharmacokinetic approach using tape stripping to assess bioequivalence of topical drugs. It offers a faster, less invasive alternative to clinical trials, accurately estimating drug absorption and diffusion. The method can streamline regulatory approval of generic dermatological products, improving affordability and access to treatments.